Cooperative Groups Advised To Plan For Future Of Less Funding from NCI
In Brief: General Motors Cancer Research Foundation Prizewinners: Brock, Li, Fraumeni, Harlow
ODAC Recommends Ethyol, DaunoXome For FDA Approval
ORI Clears Los Angeles Physician Of Misconduct In NSABP Participation
Cancer Panel Urges Improved Funding For Basic Science
FDA, NIH Streamline Approvals For Gene Therapy Studies
Report Criticizes NIH Grant Review
NIH Policy On Diversity In Sponsored Meetings
Trending Stories
- Brawley: ACS prostate cancer screening guideline should say no to “mass screening”
- NCI’s Letai, FDA’s Diamantas identify strategies to speed up cancer trials
Letai: 150 days to start a cancer trial is too long—cancer centers need to accept a little risk - ACS strengthens recommendation for prostate cancer screening
Many will hear the endorsement and ignore the limitations - Kay “Taddy” Dickersin, NBCC co-founder, dies at 74
- CMS rule cuts overall oncology payments by estimated 2%
Final rule slashes 340B, moves toward site-neutrality - Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives









